using clsi m45-a2 for antimicrobial susceptibility testing of infrequently-isolated organisms

60
Using CLSI M45-A2 for timicrobial Susceptibility Testi f Infrequently-isolated Organism Erik Munson Clinical Microbiology Wheaton Franciscan Laboratory Wauwatosa, Wisconsin he presenter states no conflict of interest and has no financial relationshi to disclose relevant to the content of this presentation.

Upload: zilya

Post on 23-Jan-2016

110 views

Category:

Documents


3 download

DESCRIPTION

Erik Munson. Clinical Microbiology Wheaton Franciscan Laboratory Wauwatosa, Wisconsin. Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms. The presenter states no conflict of interest and has no financial relationship - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Using CLSI M45-A2 forAntimicrobial Susceptibility Testingof Infrequently-isolated Organisms

Erik MunsonClinical Microbiology

Wheaton Franciscan LaboratoryWauwatosa, Wisconsin

The presenter states no conflict of interest and has no financial relationshipto disclose relevant to the content of this presentation.

Page 2: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

OUTLINE

I. M45-A2 guideline

A. Appropriate formatB. Microbiology review

II. Caveats and other intelligence for your life

A. Clinical presentationB. TaxonomyC. Antibiogram

Page 3: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

M45-A2 Methods for Antimicrobial Dilutionand Disk Susceptibility Testing ofInfrequently Isolated or FastidiousBacteria; Approved Guideline--Second Edition (2010)

BRIEF HISTORY

M45-A Ibid (2006)

M45-P Ibid (2005)

Page 4: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms
Page 5: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

You Make the Call

Page 6: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

QUESTION ONE

Can the microbiology laboratory performantimicrobial susceptibility testing on Abiotrophia spp.?

A. No

B. Possibly

C. Yes; John Tesh advised us how

D. Yes; the microbiology laboratory is omniscient

E. What *#$% is Abiotrophia spp.

Page 7: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Abiotrophia spp.; Granulicatella spp.Format Broth microdilution Disk Diffusion

MediumCation-adjusted Mueller-Hinton broth with 2.5-5.0% (v/v) lysed

horse blood plus 1 g/mL pyridoxal hydrochloride

Inoculum 20-24 h direct colony suspension equivalent to 0.5

McFarland

Incubation 35°C ambient air20-24 hours

Agents to consider for primary testing

PenicillinCefotaxime or ceftriaxone

Vancomycin

Page 8: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTESFormer nutritionally-deficient,-variant streptococci; requirescysteine or pyridoxal for growth

Testing of isolates from normally-sterile sourcesmay be warranted, especially in immunodeficientpatients

CLSI M45-A2

Interpretive criteria derived from Streptococcusspp. breakpoints (CLSI M100 series)

Diminished susceptibility to penicillin

Koneman, 5th ed.

Page 9: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

LIMITED DATA

Diagn. Microbiol. Infect. Dis. 38: 189-191; 2000

Granulicatella Abiotrophia

Penicillin 55 8

Amoxicillin 81 92

Ceftriaxone 63 83

Meropenem 96 100

46.7% susceptibility to macrolide agents

J. Clin. Microbiol. 42: 4323-4326; 2004

Page 10: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

You Make the Call

Page 11: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

CASE PRESENTATION

29-year-old female wading in Milwaukee River;fell and scraped knee on rock

Visited ER for cleaning & suturing; no antibioticsPain worsened overnight; came back to ER

Septic pre-patellar bursitis; surgical debridement

WBC 24,200/L (89.0% segmented neutrophils)Sutures removed to reveal purulent discharge

Page 12: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

QUESTION TWO

What is the most likely infectious etiologyfor this clinical presentation?

A. Methicillin-susceptible Staphylococcus aureus

B. Aeromonas species

C. Non-tuberculous Mycobacterium species

D. Pseudomonas aeruginosa

E. A 24,000 white count doesn’t really alarm me.

Page 13: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

A. hydrophila complex; P. shigelloidesFormat Broth microdilution Disk Diffusion

Medium Cation-adjustedMueller-Hinton broth

Mueller-Hinton agar

Inoculum Direct colony suspension equivalent to 0.5 McFarland

Direct colony suspension equivalent to 0.5 McFarland

Incubation 35°C ambient air16-20 hours

35°C ambient air16-18 hours

Agents to consider for primary testing

Amoxicillin-clavulanic acid3° and 4° cephemsFluoroquinolones

Trimethoprim-sulfamethoxazole

Amoxicillin-clavulanic acid3° and 4° cephemsFluoroquinolones

Trimethoprim-sulfamethoxazole

Page 14: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTESAeromonas caviae complexAeromonas hydrophila complexAeromonas veronii complex (incl. biovar sobria)Plesiomonas shigelloides

Often limited to isolates from extraintestinal sites

CLSI M45-A2

Aeromonas spp. resistant to ampicillinAmpicillin resistance in P. shigelloides unclear

Interpretive criteria derived from Enterobacteriaceaebreakpoints (CLSI M100 series)

Page 15: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Bacillus spp.Format Broth microdilution Disk Diffusion

Medium Cation-adjustedMueller-Hinton broth

Inoculum Direct colony suspension equivalent to 0.5 McFarland

Incubation 35°C ambient air16-20 hours

Agents to consider for primary testing

VancomycinFluoroquinolones

Clindamycin

Page 16: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTES

Not Bacillus anthracis

Interpretive criteria derived from Staphylococcusspp. breakpoints (CLSI M100 series)

Testing of isolates from normally-sterile sourcesmay be warranted, especially in immunodeficientpatients

CLSI M45-A2

Generally resistant to penicillins and cephems;-lactamase testing is unreliable

Page 17: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

LIMITED DATA

Antimicrob. Agents Chemother. 32: 642-645; 1988

B. cereus Non-B. cereus

Penicillin 0 40

Cefotaxime 0 71

Imipenem 100 97

Erythromycin 94 97

Clindamycin 72 40

Tetracycline 59 71

Vancomycin 100 100

Ciprofloxacin 98 100

Trimethoprim-sulfamethoxazole 0 97

Page 18: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Campylobacter jejuni/coliFormat Broth microdilution Disk Diffusion

MediumCation-adjusted Mueller-Hinton broth with 2.5-5.0% (v/v) lysed

horse blood

Mueller-Hinton agar with 5% sheep blood

Inoculum 24-48 h direct colony suspension equivalent to 0.5

McFarland

Direct colony suspension equivalent to 0.5 McFarland

Incubation 36-37°C aerophilic; 48 hours42°C aerophilic; 24 hours

36-37°C aerophilic; 48 hrs42°C aerophilic; 24 hours

Agents to consider for primary testing

ErythromycinCiprofloxacin

ErythromycinCiprofloxacin

Page 19: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTESMicroaerophilic (10% CO2, 5% O2, 85% N2)

Compressed gas incubatorMicroaerophilic gas-generating sachetsSealed plastic bags/pouches not reproducible

Testing may be useful for epidemiology or forpatients with protracted or severe symptoms

Ciprofloxacin, tetracycline interpretive criteriaderived from Enterobacteriaceae breakpoints(CLSI M100 series); population distributions

CLSI M45-A2

Page 20: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

DATA

Emerg. Infect. Dis. 8: 1501-1503; 2002

Page 21: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

You Make the Call

Page 22: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

QUESTION THREE

Can the microbiology laboratory performantimicrobial susceptibility testing on diphtheroids?

A. No

B. Possibly

C. Yes; John Tesh advised us how

D. Yes; the microbiology laboratory is omniscient

E. Do we really want to advertise this?

Page 23: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Corynebacterium spp.; CORYNEFORMSFormat Broth microdilution Disk Diffusion

MediumCation-adjusted Mueller-Hinton broth with 2.5-5.0% (v/v) lysed

horse blood; daptomycin caveat

Inoculum 20-24 h direct colony suspension equivalent to 0.5

McFarland

Incubation 35°C ambient air24-48 hours

Agents to consider for primary testing

PenicillinVancomycinGentamicin

Erythromycin

Page 24: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTESAll Corynebacterium spp. Leifsonia spp.Arcanobacterium spp. Microbacterium spp.Brevibacterium spp. Oerskovia spp.Cellulomonas spp. Rothia spp.Dermabacter spp. Turicella spp.

Testing of isolates from normally-sterile sourcesmay be warranted, especially in immunodeficientpatients

Some Corynebacterium spp. resistant to multipledrug classes

CLSI M45-A2

Page 25: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

MORE NOTES

Interpretations of “resistant” may be reported at24 hours; isolates appearing “susceptible” to -lactam agents are re-incubated to be read @ 48h

Derivations of interpretive criteria (CLSI M100)

Cephems from Streptococcus spp.Linezolid from Enterococcus spp.Penicillin, erythromycin from population distributionsRest from Staphylococcus spp.

CLSI M45-A2

Page 26: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Erysipelothrix rhusiopathiaeFormat Broth microdilution Disk Diffusion

MediumCation-adjusted Mueller-Hinton broth with 2.5-5.0% (v/v) lysed

horse blood

Inoculum 1-3 d direct colony suspension equivalent to 0.5 McFarland

Incubation 35°C ambient air20-24 hours

Agents to consider for primary testing

Penicillin or ampicillin

Page 27: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTES

Looks like -hemolytic streptococciH2S-positive

CLSI M45-A2

Testing not necessarily required

ID may be more important in context of potentiallyfulminant endocarditis (d/c empiric therapycovering Gram-positives)

Erythromycin and clindamycin testing may bewarranted in patients with penicillin allergy

gefor.4t.com

Page 28: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

MORE NOTES

Derivations of interpretive criteria (CLSI M100)

Ciprofloxacin from Staphylococcus spp.Rest from Streptococcus spp.

Intrinsic resistance to vancomycin (PELL)

CLSI M45-A2

Page 29: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Haemophilus aphrophilusHaemophilus paraphrophilusHaemophilus segnisA. actinomycetemcomitans

Aggregatibacter spp.

Hs & As

Page 30: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

(HA)CEK GROUPFormat Broth microdilution Disk Diffusion

MediumCation-adjusted Mueller-Hinton broth with 2.5-5.0% (v/v) lysed

horse blood

Inoculum 24-48 h direct colony suspension equivalent to 0.5

McFarland

Incubation 35°C with 5% CO2 enrichment24-48 hours

Agents to consider for primary testing

AmpicillinAmoxicillin-clavulanic acidCeftriaxone or cefotaxime

ImipenemCiprofloxacin or levofloxacin

Trimethoprim-sulfamethoxazole

Page 31: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTES

Aggregatibacter spp. Eikenella corrodensCardiobacterium spp. Kingella spp.

Testing of isolates from normally-sterile sourcesmay be warranted, especially in immunodeficientpatients or those unable to tolerate PO -lactams

Testing of E. corrodens isolates from bite woundsmay not be necessary due to high probability ofsusceptibility to amoxicillin-clavulanic acid

CLSI M45-A2

Page 32: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

MORE NOTES

-lactamase production predicts (most) ampicillinresistance (exception: Aggregatibacter spp.)

Watch growth control wells; could be problematic

CLSI M45-A2

Derivations of interpretive criteria (CLSI M100)

Chloramphenicol from Streptococcus spp.Penicillin from population distributionsRest from Haemophilus influenzae

Page 33: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Helicobacter pyloriFormat Broth dilution AGAR DILUTION Disk Diffusion

MediumMueller-Hinton agar with

aged (≥ 2-week-old) sheep blood (5% v/v)

Inoculum 72 h saline suspension equivalent to 2.0 McFarland

Incubation 33-37°C aerophilic72 hours

Agents to consider for primary testing

Clarithromycin main driver of a regimen that includes proton-pump inhibitor and

possibly additional antimicrobials

Page 34: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Lactobacillus spp.Format Broth microdilution Disk Diffusion

MediumCation-adjusted Mueller-Hinton broth with 2.5-5.0% (v/v) lysed

horse blood

Inoculum 24-48 h direct colony suspension equivalent to 0.5

McFarland

Incubation 35°C with 5% CO2 enrichment24-48 hours

Agents to consider for primary testing

Penicillin or ampicillinGentamicin (for combined Rx)

Page 35: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTESTesting of isolates from normally-sterile sourcesmay be warranted

CLSI M45-A2

Derivation of interpretive criteria (CLSI M100)

Gentamicin, linezolid, vancomycin fromStaphylococcus spp.

Clindamycin, imipenem from population distributions

Rest from Enterococcus spp.

Intrinsic resistance to vancomycin (PELL),particularly those that grow well in ambient air

Page 36: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

LIMITED DATA

Antimicrob. Agents Chemother. 34: 543-549; 1990

Lactobacillus

Penicillin 0

Ceftriaxone 31

Imipenem 100

Erythromycin 100

Gentamicin 100

Tetracycline 15

Chloramphenicol 100

Ciprofloxacin 38

Trimethoprim-sulfamethoxazole 0

Page 37: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Leuconostoc spp.Format Broth microdilution Disk Diffusion

MediumCation-adjusted Mueller-Hinton broth with 2.5-5.0% (v/v) lysed

horse blood

Inoculum 20-24 h direct colony suspension equivalent to 0.5

McFarland

Incubation 35°C ambient air20-24 hours

Agents to consider for primary testing

Penicillin or ampicillinGentamicin (for combined Rx)

Page 38: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTES

Interpretive criteria only provided for penicillin,ampicillin, gentamicin, chloramphenicol,minocycline

Testing of isolates from normally-sterile sourcesmay be warranted (e.g., endocarditis)

CLSI M45-A2

Intrinsic resistance to vancomycin (PELL)

Interpretive of interpretive criteria (CLSI M100)

Gentamicin from Staphylococcus spp.Rest from Enterococcus spp.

Page 39: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

LIMITED DATA

Antimicrob. Agents Chemother. 34: 543-549; 1990

Leuconostoc

Penicillin 6

Ampicillin 2

Ceftriaxone 57

Imipenem 81

Erythromycin 100

Gentamicin 100

Tetracycline 77

Chloramphenicol 98

Ciprofloxacin 24

Trimethoprim-sulfamethoxazole 70

Page 40: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Listeria monocytogenesFormat Broth microdilution Disk Diffusion

MediumCation-adjusted Mueller-Hinton broth with 2.5-5.0% (v/v) lysed

horse blood

Inoculum 20-24 h direct colony suspension equivalent to 0.5

McFarland

Incubation 35°C ambient air20-24 hours

Agents to consider for primary testing

Penicillin or ampicillinTrimethoprim-sulfamethoxazole

Page 41: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTES

Ampicillin and penicillin data previously published(CLSI M100-S15; 2005)

Trimethoprim-sulfamethoxazole interpretive criteriaderived from Streptococcus spp. breakpoints(CLSI M100 series)

Testing of isolates may be limited to suspectedtreatment failures or patients with penicillin allergy

CLSI M45-A2

Intrinsically resistant to cephems

Page 42: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Moraxella catarrhalisFormat Broth microdilution Disk Diffusion

Medium Cation-adjustedMueller-Hinton broth

Mueller-Hinton agar

Inoculum Direct colony suspension equivalent to 0.5 McFarland

Direct colony suspension equivalent to 0.5 McFarland

Incubation 35°C ambient air20-24 hours

35°C with 5% CO2 20-24 hours

Agents to consider for primary testing

Amoxicillin-clavulanic acidCefaclor or cefuroxime

Trimethoprim-sulfamethoxazole

Amoxicillin-clavulanic acid

Trimethoprim-sulfamethoxazole

Page 43: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTES

-lactamase production predicts ampicillin andamoxicillin resistance

Testing may be useful for epidemiology or forpatients with protracted or severe infections

Derivation of interpretive criteria (CLSI M100)

Macrolides from population distributionsRest from Haemophilus spp.

CLSI M45-A2

Page 44: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

DATA

J. Clin. Microbiol. 44: 3775-3777; 2006

M. catarrhalis

Penicillin 5

Amoxicillin-clavulanic acid 100

Ceftriaxone 100

Cefuroxime 99

Azithromycin 100

Levofloxacin 100

Tetracycline 99

Trimethoprim-sulfamethoxazole 93

Page 45: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

You Make the Call

Page 46: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

CASE PRESENTATION

55-year-old female bitten by family cat on R palm;progressive erythema over next 12-18 hours

Afebrile upon presentationSlightly tachycardic and tachypneicWBC 12,100/L (77.8% segmented neutrophils)Empiric ampicillin-sulbactam

Gram-negative bacillus; no growth MacConkeySusceptible to penicillin

Discharge on hospital day 3

Page 47: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

QUESTION FOUR

What is the most likely infectious etiologyfor this clinical presentation?

A. Viridans group Streptococcus

B. CDC group EF-4a

C. Pasteurella species

D. A strictly veterinary pathogen

E. I’m doomed. Help me, John Tesh!!!

Page 48: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Pasteurella spp.Format Broth microdilution Disk Diffusion

MediumCation-adjusted Mueller-Hinton broth with 2.5-5.0% (v/v) lysed

horse blood

Mueller-Hinton agar with 5% sheep blood

Inoculum 20-24 h direct colony suspension equivalent to 0.5

McFarland

20-24 h direct colony suspension equivalent to 0.5 McFarland

Incubation 35°C ambient air20-24 hours

35°C ambient air16-18 hours

Agents to consider for primary testing

PenicillinsAmoxicillin-clavulanic acid

CeftriaxoneFluoroquinolones

TetracyclinesMacrolides

Trimethoprim-sulfamethoxazole

PenicillinsAmoxicillin-clavulanic acid

CeftriaxoneFluoroquinolones

TetracyclinesMacrolides

Trimethoprim-sulfamethoxazole

Page 49: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTESRoutine testing usually not necessary on isolatesfrom bite wounds; empiric therapy for polymicrobialinfection

Testing of isolates from normally-sterile sourcesmay be warranted, especially in immunodeficientpatients

Interpretive criteria derived from populationdistributions

CLSI M45-A2

-lactamase testing can have value; rare isolateswith penicillin, amoxicillin MIC > 0.5 g/mL

Page 50: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Pediococcus spp.Format Broth microdilution Disk Diffusion

MediumCation-adjusted Mueller-Hinton broth with 2.5-5.0% (v/v) lysed

horse blood

Inoculum 20-24 h direct colony suspension equivalent to 0.5

McFarland

Incubation 35°C ambient air20-24 hours

Agents to consider for primary testing

Penicillin or ampicillinGentamicin (for combined Rx)

Page 51: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTES

Derivations of interpretive criteria (CLSI M100)

Gentamicin from Staphylococcus spp.Rest from Enterococcus spp.

Interpretive criteria only provided for penicillin,ampicillin, gentamicin, chloramphenicol,imipenem

CLSI M45-A2

Testing of isolates from normally-sterile sourcesmay be warranted, especially in immunodeficientpatients

Intrinsic resistance to vancomycin (PELL)

Page 52: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

LIMITED DATA

Antimicrob. Agents Chemother. 34: 543-549; 1990

Pediococcus

Penicillin 0

Ampicillin 0

Ceftriaxone 38

Imipenem 100

Erythromycin 92

Gentamicin 100

Tetracycline 4

Chloramphenicol 100

Ciprofloxacin 0

Trimethoprim-sulfamethoxazole 54

Page 53: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Vibrio spp.Format Broth microdilution Disk Diffusion

Medium Cation-adjustedMueller-Hinton broth

Mueller-Hinton agar

Inoculum 20-24 h direct colony suspension equivalent to 0.5

McFarland

20-24 h direct colony suspension equivalent to 0.5 McFarland

Incubation 33-37°C ambient air16-20 hours

33-37°C ambient air16-18 hours

Agents to consider for primary testing

CefotaximeCeftazidimeTetracycline

Fluoroquinolones

CefotaximeCeftazidimeTetracycline

Fluoroquinolones

Page 54: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

Vibrio choleraeFormat Broth microdilution Disk Diffusion

Medium Cation-adjustedMueller-Hinton broth

Mueller-Hinton agar

Inoculum 20-24 h direct colony suspension equivalent to 0.5

McFarland

20-24 h direct colony suspension equivalent to 0.5 McFarland

Incubation 33-37°C ambient air16-20 hours

33-37°C ambient air16-18 hours

Agents to consider for primary testing

AzithromycinDoxycycline

SulfonamidesChloramphenicol

AmpicillinTetracycline

Trimethoprim-sulfamethoxazole

AzithromycinDoxycycline

SulfonamidesChloramphenicol

AmpicillinTetracycline

Trimethoprim-sulfamethoxazole

Page 55: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

NOTESDirect colony suspension in 0.85% saline; obviatesneed to supplement Mueller-Hinton-based medium

Testing most often limited to isolates fromextraintestinal sites

CLSI M45-A2

Derivations of interpretive criteria (CLSI M100)

Azithromycin from Staphylococcus spp.Rest from Enterobacteriaceae

Halophilic Vibrio spp. generally resistant to penicillin, sulfonamides, some cephems

Page 56: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

You Make the Call

Page 57: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

QUESTION FIVE

What does all of this mean to you (i.e., how willyour knowledge of M45-A2 impact your workplace)?

A. We’re all good.

B. Dude, we could perform AST on more isolates!!

C. We’re going to stop “incorrect” practices.

D. We’re going to change to correct practices.

E. Sorry--I’m just waking up from my food coma; I need another cookie.

Page 58: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

SUMMARY

Gram-positive organisms with intrinsicglycopeptide resistance

Organisms that previously lacked defined methods

Coryneform bacteria Bacillus (not anthracis)Abiotrophia Granulicatella

Fastidious Gram-negative organisms

(HA)CEKs Pasteurella

More-detailed guidance

Campylobacter Listeria monocytogenesM. catarrhalis Aeromonas/Plesiomonas

Page 59: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

SUMMARYAbiotrophia, Granulicatella

Aeromonas, Plesiomonas

Bacillus (not anthracis)

Campylobacter jejuni/coli

Corynebacterium

Erysipelothrix rhusiopathiae

(HA)CEK group

Helicobacter pylori

Lactobacillus

Leuconostoc

Listeria monocytogenes

Moraxella catarrhalis

Pasteurella

Pediococcus

Vibrio

Page 60: Using CLSI M45-A2 for Antimicrobial Susceptibility Testing of Infrequently-isolated Organisms

THE END

Stuff we missed

Bioterrorism agents (formerly in CLSI M100)

AFB, Nocardia, other actinomycetes (CLSI M11-A8)Anaerobes (CLSI M11-A8)Yeast and moulds (CLSI M27-A3, M44-A2, M38-A2, M51-A)

Yes, we can (sort of)